Relations of magnesium intake to cognitive impairment and dementia among participants in the Women's Health Initiative Memory Study: a prospective cohort study

Kenneth Lo, Qing Liu, Tracy Madsen, Steve Rapp, Jiu-Chiuan Chen, Marian Neuhouser, Aladdin Shadyab, Lubna Pal, Xiaochen Lin, Sally Shumaker, JoAnn Manson, Ying-Qing Feng, Simin Liu, Kenneth Lo, Qing Liu, Tracy Madsen, Steve Rapp, Jiu-Chiuan Chen, Marian Neuhouser, Aladdin Shadyab, Lubna Pal, Xiaochen Lin, Sally Shumaker, JoAnn Manson, Ying-Qing Feng, Simin Liu

Abstract

Objective: To examine the associations of dietary and supplemental magnesium (Mg) as assessed by a semi-quantitative food frequency questionnaire with cognitive outcomes among ageing women.

Design: This work conducts a prospective cohort study of participants enrolled in the Women's Health Initiative Memory Study (WHIMS), which was subsequently extended and named WHIMS-Epidemiology of Cognitive Health.

Setting: Forty clinical centres in the USA.

Participants: Postmenopausal women aged 65-79 years without dementia on enrolment.

Main outcome measures: Physician-adjudicated mild cognitive impairment (MCI) and/or probable dementia (PD).

Results: Participants were excluded (n=1006) if they had extreme values of dietary energy intake, had missing or extreme body mass index values, with prevalent MCI/PD at baseline, received only one cognitive assessment or had been followed up for <1 year. During >20 years of follow-up, 765 (11.8%) out of 6473 participants developed MCI/PD. For MCI/PD and MCI, the risks tended to be lower among participants in quintiles Q2-Q5 of Mg consumption compared with those in the lowest quintile. Participants in Q3 had a significantly lower risk of MCI/PD (HR 0.69, 95% CI 0.53 to 0.91) and MCI (HR 0.63, 95% CI 0.45 to 0.87) after multivariate adjustments. No significant association was observed between total Mg intake and PD. The association between total Mg intake, MCI/PD and MCI was non-linear as suggested by the likelihood test.

Conclusions: Total Mg intake between the estimated average requirement and the recommended dietary allowances may associate with a lower risk of MCI/PD and MCI.

Trial registration number: NCT00685009.

Keywords: dementia; epidemiology; nutrition & dietetics.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

References

    1. Petersen RC, Smith GE, Waring SC, et al. . Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303–8. 10.1001/archneur.56.3.303
    1. Arevalo-Rodriguez I, Smailagic N, Roqué I Figuls M, et al. . Mini-Mental state examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev 2015:CD010783 10.1002/14651858.CD010783.pub2
    1. World Health Organization The epidemiology and impact of dementia current state and future trends 2015.
    1. Andersen K, Launer LJ, Dewey ME, et al. . Gender differences in the incidence of AD and vascular dementia: the EURODEM studies. EURODEM incidence Research Group. Neurology 1999;53:1992–7. 10.1212/wnl.53.9.1992
    1. Chêne G, Beiser A, Au R, et al. . Gender and incidence of dementia in the Framingham heart study from mid-adult life. Alzheimer's & Dementia 2015;11:310–20. 10.1016/j.jalz.2013.10.005
    1. Lin KA, Choudhury KR, Rathakrishnan BG, et al. . Marked gender differences in progression of mild cognitive impairment over 8 years. Alzheimers Dement 2015;1:103–10. 10.1016/j.trci.2015.07.001
    1. Parsons CG, Danysz W, Quack G. Glutamate in CNS disorders as a target for drug development: an update. Drug News Perspect 1998;11:523–69. 10.1358/dnp.1998.11.9.863689
    1. Hynd M, Scott HL, Dodd PR. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer?s disease. Neurochem Int 2004;45:583–95. 10.1016/j.neuint.2004.03.007
    1. Ozawa M, Ninomiya T, Ohara T, et al. . Self-Reported dietary intake of potassium, calcium, and magnesium and risk of dementia in the Japanese: the Hisayama study. J Am Geriatr Soc 2012;60:1515–20. 10.1111/j.1532-5415.2012.04061.x
    1. Tzeng N-S, Chung C-H, Lin F-H, et al. . Magnesium oxide use and reduced risk of dementia: a retrospective, nationwide cohort study in Taiwan. Curr Med Res Opin 2018;34:163–9. 10.1080/03007995.2017.1385449
    1. Shumaker SA, Reboussin BA, Espeland MA, et al. . The women's health Initiative memory study (WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Control Clin Trials 1998;19:604–21.
    1. Rapp SR, Espeland MA, Shumaker SA, et al. . Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the women's health Initiative memory study: a randomized controlled trial. JAMA 2003;289:2663–72. 10.1001/jama.289.20.2663
    1. Malouf R, Areosa Sastre A. Vitamin B12 for cognition. Cochrane Database Syst Rev 2003:CD004326 10.1002/14651858.CD004394
    1. Welsh KA, Breitner J, Magruder-Habib KM. Detection of dementia in the elderly using the telephone interview for cognitive status. Neuropsychiatry Neuropsychol Behav Neurol 1993;6:103–10.
    1. Rapp SR, Legault C, Espeland MA, et al. . Validation of a cognitive assessment battery administered over the telephone. J Am Geriatr Soc 2012;60:1616–23. 10.1111/j.1532-5415.2012.04111.x 10.1111/j.1532-5415.2012.04111.x
    1. Arnold AM, Newman AB, Dermond N, et al. . Using telephone and informant assessments to estimate missing modified Mini-Mental state exam scores and rates of cognitive decline. Neuroepidemiology 2009;33:55–65. 10.1159/000215830
    1. Espeland MA, Chen JC, Weitlauf J, et al. . Trajectories of relative performance with 2 measures of global cognitive function. J Am Geriatr Soc 2018.
    1. Ellis RJ, Jan K, Kawas C, et al. . Diagnostic validity of the dementia questionnaire for Alzheimer disease. Arch Neurol 1998;55:360–5. 10.1001/archneur.55.3.360
    1. Shumaker SA, Legault C, Rapp SR, et al. . Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the women's health Initiative memory study: a randomized controlled trial. JAMA 2003;289:2651–62. 10.1001/jama.289.20.2651
    1. Hogervorst E, Bandelow S, Combrinck M, et al. . The validity and reliability of 6 sets of clinical criteria to classify Alzheimer's disease and vascular dementia in cases confirmed post-mortem: added value of a decision tree approach. Dement Geriatr Cogn Disord 2003;16:170–80. 10.1159/000071006
    1. Patterson RE, Kristal AR, Tinker LF, et al. . Measurement characteristics of the women's health Initiative food frequency questionnaire. Ann Epidemiol 1999;9:178–87. 10.1016/S1047-2797(98)00055-6
    1. Schakel SF, Sievert YA, Buzzard IM. Sources of data for developing and maintaining a nutrient database. J Am Diet Assoc 1988;88:1268–71.
    1. Neuhouser ML, Wassertheil-Smoller S, Thomson C, et al. . Multivitamin use and risk of cancer and cardiovascular disease in the women's health Initiative cohorts. Arch Intern Med 2009;169:294–304. 10.1001/archinternmed.2008.540
    1. Patterson RE, Levy L, Tinker LF, et al. . Evaluation of a simplified vitamin supplement inventory developed for the women's health Initiative. Public Health Nutr 1999;2:273–6. 10.1017/S1368980099000361
    1. Ammann EM, Pottala JV, Robinson JG, et al. . Erythrocyte omega-3 fatty acids are inversely associated with incident dementia: secondary analyses of longitudinal data from the women's health Initiative memory study (WHIMS). Prostaglandins Leukot Essent Fatty Acids 2017;121:68–75. 10.1016/j.plefa.2017.06.006
    1. Hayden KM, Beavers DP, Steck SE, et al. . The association between an inflammatory diet and global cognitive function and incident dementia in older women: the women's health Initiative memory study. Alzheimers Dement 2017;13:1187–96. 10.1016/j.jalz.2017.04.004
    1. Agnew-Blais JC, Wassertheil-Smoller S, Kang JH, et al. . Folate, vitamin B-6, and vitamin B-12 intake and mild cognitive impairment and probable dementia in the women's health Initiative memory study. J Acad Nutr Diet 2015;115:231–41. 10.1016/j.jand.2014.07.006
    1. Moga DC, Abner EL, Brouwer ES. Dementia and "obesity paradox": is this for real or are we missing something? An epidemiologist's perspective. J Am Med Dir Assoc 2015;16:78–9. 10.1016/j.jamda.2014.06.009
    1. Batty GD, Shipley MJ, Kvaavik E, et al. . Biomarker assessment of tobacco smoking exposure and risk of dementia death: pooling of individual participant data from 14 cohort studies. J Epidemiol Community Health 2018;72:513–5. 10.1136/jech-2017-209922
    1. Xu W, Tan L, Wang H-F, et al. . Education and risk of dementia: dose-response meta-analysis of prospective cohort studies. Mol Neurobiol 2016;53:3113–23. 10.1007/s12035-015-9211-5
    1. Littlejohns TJ, Henley WE, Lang IA, et al. . Vitamin D and the risk of dementia and Alzheimer disease. Neurology 2014;83:920–8. 10.1212/WNL.0000000000000755
    1. Kern J, Kern S, Blennow K, et al. . Calcium supplementation and risk of dementia in women with cerebrovascular disease. Neurology 2016;87:1674–80. 10.1212/WNL.0000000000003111
    1. Ilomaki J, Jokanovic N, Tan E, et al. . And cognitive decline: an overview of systematic reviews. Curr Clin Pharmacol 2015;10:204–12. 10.2174/157488471003150820145539 10.2174/157488471003150820145539
    1. Blondell SJ, Hammersley-Mather R, Veerman JL. Does physical activity prevent cognitive decline and dementia?: a systematic review and meta-analysis of longitudinal studies. BMC Public Health 2014;14:510 10.1186/1471-2458-14-510
    1. Espeland MA, Brinton RD, Hugenschmidt C, et al. . Impact of type 2 diabetes and postmenopausal hormone therapy on incidence of cognitive impairment in older women. Diabetes Care 2015;38:2316–24. 10.2337/dc15-1385
    1. Eriksson UK, Bennet AM, Gatz M, et al. . Nonstroke cardiovascular disease and risk of Alzheimer disease and dementia. Alzheimer Dis Assoc Disord 2010;24:1–9. 10.1097/WAD.0b013e3181d1b99b
    1. Ganguli M, Cancer GM. Cancer and dementia: it's complicated. Alzheimer Dis Assoc Disord 2015;29:177–82. 10.1097/WAD.0000000000000086
    1. Yaffe K, Sawaya G, Lieberburg I, et al. . Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 1998;279:688–95. 10.1001/jama.279.9.688
    1. Peters R, Beckett N, Hypertension BN. Hypertension, dementia, and antihypertensive treatment: implications for the very elderly. Curr Hypertens Rep 2009;11:277–82. 10.1007/s11906-009-0047-0
    1. Reitz C. Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations. J Alzheimers Dis 2012;30 Suppl 2:S127–45. 10.3233/JAD-2011-110599
    1. Jick H, Zornberg GL, Jick SS, et al. . Statins and the risk of dementia. The Lancet 2000;356:1627–31. 10.1016/S0140-6736(00)03155-X
    1. Tully PJ, Hanon O, Cosh S, et al. . Diuretic antihypertensive drugs and incident dementia risk: a systematic review, meta-analysis and meta-regression of prospective studies. J Hypertens 2016;34:1027–35. 10.1097/HJH.0000000000000868
    1. Kieboom BCT, Licher S, Wolters FJ, et al. . Serum magnesium is associated with the risk of dementia. Neurology 2017;89:1716–22. 10.1212/WNL.0000000000004517
    1. Bergman C, Gray-Scott D, Chen J-J, et al. . What is next for the dietary reference intakes for bone metabolism related nutrients beyond calcium: phosphorus, magnesium, vitamin D, and fluoride? Crit Rev Food Sci Nutr 2009;49:136–44. 10.1080/10408390701764468
    1. Murphy SP, Poos MI. Dietary reference intakes: summary of applications in dietary assessment. Public Health Nutr 2002;5:843–9. 10.1079/PHN2002389 10.1079/PHN2002389
    1. Chen GC, Koh WP, Yuan JM, et al. . Green leafy and cruciferous vegetable consumption and risk of type 2 diabetes: results from the Singapore Chinese Health study and meta-analysis. Br J Nutr 2018:1–11.
    1. Akizawa Y, Koizumi S, Itokawa Y, et al. . Daily magnesium intake and serum magnesium concentration among Japanese people. J Epidemiol 2008;18:151–9. 10.2188/jea.JE2007381
    1. Han H, Fang X, Wei X, et al. . Dose-Response relationship between dietary magnesium intake, serum magnesium concentration and risk of hypertension: a systematic review and meta-analysis of prospective cohort studies. Nutr J 2017;16:26 10.1186/s12937-017-0247-4 10.1186/s12937-017-0247-4

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren